Law360
Sunshine Overseas: Transparency Rules For Life Sciences
November 2012
In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.
Contacts
Capabilities
Suggested News & Insights
Sidley Medicaid Drug Rebate Program Summit Cocktail ReceptionMonday, October 5, 2026Court Holds Insurer Must Cover FCA Settlement Despite “Fraudulent Acts” ExclusionOctober 2, 2026DOJ Continues to Prioritize Medicare Advantage Enforcement with $22.5 Million SettlementOctober 1, 2026Sidley Represents Jiangsu Hengrui in Connection With US$2.6 Billion Licensing Agreement With Novo NordiskOctober 1, 2026Texas Medicaid Fraud Decision Leaves 2 Open QuestionsOctober 1, 2026D.C. U.S. Attorney’s Office Announces Creation of Standalone Division Focused on False Claims Act EnforcementSeptember 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory